Positive reports about hormone therapy for women in their 50s started emerging as early as 2003, and they have never really slowed…
This content was originally published here.
The Menopause Association is a 501(c)(3) nonprofit organization committed to empowering women during the menopause transition and beyond. We offer evidence-based education, practical resources, and a supportive community to help women navigate this life stage with confidence and clarity. Through advocacy, expert-led initiatives, and holistic wellness programs, we work to destigmatize menopause, promote informed decision-making, and foster a vibrant network where women can connect, learn, and thrive.
On July 17, 2025, the U.S. Food and Drug Administration (FDA) hosted a landmark expert panel to address longstanding controversies surrounding hormone replacement therapy (HRT)
Dr. Howard Hodis, professor of medicine and a landmark figure in cardiovascular research, delivered a thorough analysis of how HRT timing determines its effect profile.
Dr. Rachel S. Rubin, fellowship-trained urologist and sexual medicine expert, used her time to elevate the discussion around genital and urinary syndrome of menopause (GSM).
Mary Jane Minkin, MD, veteran OB/GYN and menopause educator, presented a comprehensive critique of the “one-size-fits-all” black box warning on estrogen therapies, focusing especially on
Dr. Kelly Casperson brought a unique perspective as a urologist and sexual health expert, focusing attention on the regulatory and clinical neglect faced by women
Dr. Vonda Wright, a leading authority on musculoskeletal health and aging, offered a no-nonsense appraisal of estrogen’s role in maintaining bone health after menopause. Describing
